GE Healthcare Enters Personalized Rx Space with $5M Investment in CardioDx

The infusion of funding into CardioDx represents the first investment of GE's $250 million Healthymagination Fund, which was launched in October and plans to invest in "highly promising" young companies developing life sciences tools, diagnostics, or healthcare information technologies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.